Access Statistics for Pierre Dubois

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Academic Journals as Two-Sided Platforms: Empirical Evidence from Data on French Libraries 0 1 1 93 0 3 5 401
Academic journals as two-sided platforms: empirical evidence from data on french libraries 0 0 0 83 0 2 3 304
Antibiotic Demand in the Presence of Antimicrobial Resistance 0 0 1 1 0 2 6 6
Antibiotic Demand in the Presence of Antimicrobial Resistance 0 0 3 21 0 3 13 29
Antibiotic Demand in the Presence of Antimicrobial Resistance 0 0 0 1 0 0 3 4
Bargaining and International Reference Pricing in the Pharmaceutical Industry 0 0 0 12 2 27 49 98
Bargaining and International Reference Pricing in the Pharmaceutical Industry 0 0 2 5 0 3 12 25
Bargaining and International Reference Pricing in the Pharmaceutical Industry 0 0 1 16 2 17 29 88
Bargaining and International Reference Pricing in the Pharmaceutical Industry 0 0 1 6 1 4 6 12
Child Care Provision: Semiparametric Evidence from a Randomized Experiment in Mexico 0 0 0 27 0 1 5 159
Child Care Provision: Semiparametric Evidence from a Randomized Experiment in Mexico 0 0 0 31 2 14 17 176
Child Care Provision: Semiparametric Evidence from a Randomized Experiment in Mexico 0 0 0 64 0 2 6 266
Consumer Demand with Unobserved Stockpiling and Intertemporal Price Discrimination 0 0 0 100 2 6 15 117
Consumption Insurance with Heterogeneous Preferences. Can Sharecropping Help Complete Markets? 0 0 0 128 0 3 7 443
Consumption insurance with heterogeneous preferences. Can sharecropping help complete markets ? 0 0 0 163 1 7 8 1,283
Do Prices and Attributes Explain International Differences in Food Purchases? 0 0 0 47 0 11 17 179
Do Prices and Attributes Explain International Differences in Food Purchases? 0 0 0 17 1 12 15 187
Do Prices and Attributes Explain International Differences in Food Purchases? 0 0 0 75 1 6 11 259
Do Prices and Attributes Explain International Differences in Food Purchases? 0 0 1 51 0 7 16 234
Drug Shortages: Empirical Evidence from France 0 0 3 24 1 10 32 63
Drug shortages: empirical evidence from France 0 1 1 1 0 5 8 8
Effects of front-of-pack labels on the nutritional quality of supermarket food purchases: evidence from a large-scale randomized controlled trial 0 0 0 8 0 1 8 31
Effects of front-of-pack labels on the nutritional quality of supermarket food purchases: evidence from a large-scale randomized controlled trial 0 0 1 34 1 7 16 63
Effects of front-of-pack labels on the nutritional quality of supermarket food purchases: evidence from a large-scale randomized controlled trial 0 0 0 11 0 6 11 32
Effects on School Enrollment and Performance of a Conditional Cash Transfers Program in Mexico 0 0 0 246 0 3 16 670
Effects on School Enrollment and Performance of a Conditional Transfers Program in Mexico 0 0 0 13 1 6 10 143
Effects on School Enrollment and Performance of a Conditional Transfers Program in Mexico 0 0 0 10 0 1 2 70
Effects on School Enrollment and Performance of a Conditional Transfers Program in Mexico 0 0 0 3 1 7 9 27
Effects on school enrollment and performance of a conditional transfers program in Mexico 0 0 0 191 0 5 9 1,040
Empirical Evidence on Satisfaction with Privatization in Latin America 0 0 0 0 0 0 2 6
Empirical Evidence on Satisfaction with Privatization in Latin America 0 0 0 0 1 2 5 16
Empirical Evidence on Satisfaction with Privatization in Latin America: Welfare Effects and Beliefs 0 0 0 77 1 4 8 239
Empirical Evidence on Satisfaction with Privatization in Latin America: Welfare Effects and Beliefs 0 0 0 14 0 6 9 119
Empirical Evidence on the Role of Non Linear Wholesale Pricing and Vertical Restraints on Cost Pass-Through 0 0 2 107 1 8 14 209
Empirical Evidence on the Role of Non Linear Wholesale Pricing and Vertical Restraints on Cost Pass-Through 1 1 1 21 2 3 8 141
Empirical Evidence on the Role of Non Linear Wholesale Pricing and Vertical Restraints on Cost Pass-Through 0 0 0 17 0 3 5 139
Empirical Evidence on the Role of Non Linear Wholesale Pricing and Vertical Restraints on Cost Pass-Through 0 0 0 62 0 3 8 266
Empirical Evidence on the Role of Non Linear Wholesale Pricing and Vertical Restraints on Cost Pass-Through 0 0 2 13 1 5 11 71
Empirical evidence on the role nonlinear wholesale pricing and vertical restraints on cost pass-trough 0 0 0 0 0 3 11 19
Empirical evidence on the role of non linear wholesale pricing and vertical restraints on cost pass-through 0 0 0 0 2 9 14 40
Environmental Regulation of Livestock Production Contracts 0 0 0 0 0 4 5 123
Estimating the Benefits of Cancer Treatments 0 0 0 0 1 2 3 12
Estimating the Benefits of Innovation 0 0 0 0 0 2 4 48
Formal and Informal Risk Sharing in LDCs: Theory and Empirical Evidence 0 0 0 80 2 11 14 366
Formal and Informal Risk Sharing in LDCs: Theory and Empirical Evidence 0 0 0 27 0 5 7 186
Formal and Informal Risk Sharing in LDCs: Theory and Empirical Evidence 0 0 0 34 4 12 14 216
Formal and Informal Risk Sharing in LDCs: Theory and Empirical Evidence 0 0 0 28 1 6 8 232
Formal and Informal Risk Sharing in LDCs: Theory and Empirical Evidence 0 0 0 35 0 7 10 218
Formal and informal risk sharing in LDCs: theory and empirical evidence 0 0 0 0 2 15 17 37
Formal and informal risk sharing in LDCs: theory and empirical evidence 0 0 0 132 1 7 18 472
Grower Risk Aversion and the Cost of Moral Hazard in Livestock Production Contracts 0 0 0 0 0 2 6 141
Heterogeneity of Preferences, Limited Commitment and Coalitions Empirical Evidence on the Limits to Risk Sharing in Rural Pakistan 0 0 0 27 0 2 6 97
Heterogeneity of Preferences, Limited Commitment and Coalitions: Empirical Evidence on the Limits to Risk Sharing in Rural Paki 0 0 0 67 0 1 3 178
Heterogeneity of preferences, limited commitment and coalitions: empirical evidence on the limits to risk sharing in rural Pakistan 0 0 0 45 0 4 8 236
Household Food Consumption, Individual Caloric Intake and Obesity in France 0 0 0 71 0 1 3 283
Household Food Consumption, Individual Caloric Intake and Obesity in France 0 0 0 24 0 2 3 223
How well targeted are soda taxes? 1 1 1 102 2 11 17 338
How well targeted are soda taxes? 1 1 1 77 2 6 8 185
How well targeted are soda taxes? 0 1 1 31 0 6 18 81
How well targeted are soda taxes? 0 0 0 16 0 4 7 17
Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals 0 0 1 52 2 12 18 136
Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals 0 0 0 13 1 6 10 80
Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals 0 0 0 14 0 0 2 98
Identifying Two Part Tariff Contracts with Buyer Power: Empirical Estimation on Food Retailing 0 0 0 58 1 7 11 85
Identifying Two Part Tariff Contracts with Buyer Power: Empirical Estimation on Food Retailing 0 0 0 26 1 4 6 62
Identifying the Effect of Unobserved Quality and Expert Reviews in the Pricing of Experience Goods: Empirical Application on Bordeaux Wine 0 0 0 45 0 12 21 241
Identifying the Effect of Unobserved Quality and Experts' Reviews in the Pricing of Experience Goods: Empirical Application on Bordeaux Wine 0 0 0 52 0 4 6 224
Identifying the Effects of Scientific Information and Recommendations on Physicians’ Prescribing Behavior 0 0 1 16 0 3 6 25
Identifying the effect of unobserved quality and experts' reviews in the pricing of experience goods: empirical application on Bordeaux wine 0 0 0 62 1 8 15 353
Identifying the effects of scientific information and recommendations on physicians’ prescribing behavior 0 1 1 1 0 6 6 6
Impact of Analytic and Synthetic Front-of-pack Graphical Nutrition Labels on the Nutritional Quality of Supermarket Food Purchases: Evidence from a French Randomized Control Experiment 0 0 0 0 0 0 4 89
Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010 0 0 0 69 1 2 5 100
Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010 0 0 0 24 0 8 14 77
Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010 0 0 0 75 2 7 12 91
Incentives & Nutrition For Rotten Kids: The Quantity & Quality Of Food Allocated Within Philippine Households 0 0 0 0 0 5 6 12
Incentives & Nutrition for Rotten Kids: The Quantity & Quality of Food Allocated within Philippine Households 0 0 0 22 0 4 11 116
Incentives and nutrition for rotten kids: intrahousehold food allocation in the Philippines 1 1 3 14 1 6 11 47
Incentives and nutrition for rotten kids: intrahousehold food allocation in the Philippines 0 0 0 10 0 4 7 80
Incentives to Invest in Short-term vs. Long-term Contracts: Evidence from a Natural Experiment 0 0 0 29 0 1 4 239
Incentives to Invest in Short-term vs. Long-term Contracts: Evidence from a Natural Experiment 0 1 1 56 1 7 9 246
Inference on Vertical Contracts between Manufacturers and Retailers Allowing for Non Linear Pricing and Resale Price Maintenanc 0 0 1 42 0 2 6 205
Inference on Vertical Contracts between Manufacturers and Retailers Allowing for Non Linear Pricing and Resale Price Maintenance 0 0 1 104 1 6 17 322
Inference on Vertical Contracts between Manufacturers and Retailers Allowing for Nonlinear Pricing and Resale Price Maintenance 0 0 3 58 1 9 19 206
Inference on Vertical Contracts between Manufacturers and Retailers Allowing for Nonlinear Pricing and Resale Price Maintenance 0 0 2 54 1 5 9 223
Introduction to the special issue on the econometrics of auctions 0 0 0 1 1 4 6 10
Market Size and Pharmaceutical Innovation 0 0 0 37 3 10 19 229
Market Size and Pharmaceutical Innovation 0 0 0 71 1 10 14 262
Market Size and Pharmaceutical Innovation 0 0 2 311 0 12 24 808
Mergers and Advertising in the Pharmaceutical Industry 1 1 3 35 1 19 41 90
Mergers and Advertising in the Pharmaceutical Industry 0 0 0 2 0 1 7 17
Mergers and advertising in the pharmaceutical industry 1 1 1 1 3 8 13 13
Mitigating Contractual Hazards: Short-term vs. Long-term Contracting in Animal Agriculture 0 0 0 6 0 2 5 51
Moral Hazard, Land Fertility and Sharecropping in a Rural Area of the Philippines 0 0 0 64 1 7 10 280
Multitask moral hazard, incentive contracts and land value 0 0 0 313 1 2 5 1,360
Non Linear Contracting and Endogenous Buyer Power between Manufacturers and Retailers: Empirical Evidence on Food Retailing in 0 0 0 54 1 3 7 133
Non Linear Contracting and Endogenous Buyer Power between Manufacturers and Retailers: Empirical Evidence on Food Retailing in France 0 0 0 48 1 5 7 168
Non Linear Contracting and Endogenous Buyer Power between Manufacturers and Retailers: Empirical Evidence on Food Retailing in France 0 0 0 25 1 3 9 108
Nutrition and Risk Sharing Within the Household 0 0 0 21 0 3 5 132
Nutrition and Risk Sharing within the Household 0 0 0 5 1 6 8 65
Nutrition and Risk Sharing within the Household 0 0 0 20 0 6 10 135
Nutrition and Risk Sharing within the Household 0 0 0 78 0 11 13 174
On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector 0 0 0 20 0 5 16 72
On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector 0 0 0 41 4 9 14 155
On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector 0 0 0 0 1 22 28 46
On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector 0 0 0 21 2 6 10 80
Optimal Incentives Under Moral Hazard and Heterogeneous Agents: Evidence from Production Contracts Data 0 0 0 16 0 7 9 108
Optimal Incentives under Moral Hazard and Heterogeneous Agents: Evidence from Production Contracts Data 0 0 0 76 0 4 7 259
Optimal Incentives under Moral Hazard and Heterogeneous Agents: Evidence from Production Contracts Data 0 0 0 9 4 16 24 107
Optimal Incentives under Moral Hazard and Heterogeneous Agents: Evidence from Production Contracts Data 0 0 0 31 0 4 7 212
Optimal Intertemporal Curative Drug Expenses: The Case of Hepatitis C in France 0 0 1 5 0 5 8 12
Optimal Intertemporal Curative Drug Expenses: The Case of Hepatitis C in France 0 0 0 18 1 3 8 15
Optimal Regulation of Private Production Contracts with Environmental Externalities 0 0 0 0 0 5 7 86
Optimal incentives under moral hazard and heterogeneous agents: evidence from production contracts data 0 0 1 48 2 5 9 285
Optimal regulation of private production contracts with environmental externalities 0 0 0 0 0 2 4 14
Pharmaceutical Regulation and Incentives for Innovation in an International Perspective 0 0 0 0 1 5 7 7
Pharmaceutical Regulation and Incentives for Innovation in an International Perspective 0 1 21 21 2 13 47 47
Pooled Procurement of Drugs in Low and Middle Income Countries 0 0 0 20 1 5 11 89
Pooled Procurement of Drugs in Low and Middle Income Countries 0 0 0 12 2 6 12 63
Price Dispersion and Informational Frictions: Evidence From Supermarket Purchases 0 0 2 61 0 15 20 184
Price Dispersion and Informational Frictions: Evidence from Supermarket Purchases 0 0 0 54 1 5 7 83
Price Dispersion and Informational Frictions: Evidence from Supermarket Purchases 0 0 0 54 0 2 6 85
Price and Brand Competition between Differentiated Retailers: A Structural Econometric Model 0 0 1 178 0 1 2 2,735
Price and Brand Competition between Differentiated Retailers: A Structural Econometric Model 0 0 1 42 1 1 4 157
Price and Brand Competition between Differentiated Retailers: A Structural Econometric Model 0 0 0 87 1 4 6 348
Product Design and Decision Rights in Vertical Structures 0 0 0 28 3 10 18 46
Productivity and Mobility in Academic Research: Evidence from Mathematicians 0 0 0 9 0 6 9 89
Productivity and Mobility in Academic Research: Evidence from Mathematicians 0 0 1 68 0 4 9 206
Rotten Parents and Child Labor 0 1 1 281 2 7 8 1,688
Smoking within the Household: Spousal Peer Effects and Children's Health Implications 0 0 0 36 2 14 18 181
Smoking within the Household: Spousal Peer Effects and Children's Health Implications 0 0 0 55 0 3 8 191
Strategic Submissions: A Cross-Country Analysis of Supplemental Drug Approvals 0 0 2 2 0 2 6 7
Strategic Submissions: A Cross-Country Analysis of Supplemental Drug Approvals 0 0 0 0 2 11 14 14
Strategic Submissions: An Analysis of Supplemental Drug Approvals 0 0 1 2 0 2 7 11
Study on the economic and technical evolution of the scientific publication markets in Europe 0 3 3 114 0 7 14 516
The (Ir)Relevance of the Cooperative Form 0 0 0 0 0 3 4 4
The (Ir)Relevance of the Cooperative Form 0 0 1 61 0 9 18 120
The Economics of Transferable Patent Extensions 0 1 2 33 1 6 12 65
The Effects of Banning Advertising on Demand, Supply and Welfare: Structural Estimation on a Junk Food Market 0 0 1 63 0 6 12 214
The Effects of Banning Advertising on Demand, Supply and Welfare: Structural Estimation on a Junk Food Market 0 0 0 37 0 1 14 137
The Effects of Pharmaceutical Innovation on Cancer Mortality 0 0 1 11 0 2 13 58
The Effects of Pharmaceutical Innovation on Cancer Mortality Rates 3 3 4 102 5 8 20 219
The Effects of Sin Taxes and Advertising Restrictions in a Dynamic Equilibrium 0 0 0 0 1 10 16 17
The Effects of Sin Taxes and Advertising Restrictions in a Dynamic Equilibrium 0 0 0 19 0 10 17 44
The Effects of Sin Taxes and Advertising Restrictions in a Dynamic Equilibrium 0 0 0 0 0 4 5 5
The Market of Academic Journals: Empirical Evidence from Data on French Libraries 0 0 0 53 1 3 6 244
The Use of Scanner Data for Economics Research 0 0 0 4 0 7 15 31
The Use of Scanner Data for Economics Research 0 0 1 14 6 37 49 129
The Use of Scanner Data for Economics Research 0 0 2 28 9 35 44 68
The economics of transferable patent extensions 1 1 3 3 1 6 11 11
The effects of banning advertising in junk food markets 0 0 0 36 1 10 15 101
The effects of banning advertising in junk food markets 0 0 0 51 2 6 11 108
The effects of price regulation of pharmaceutical industry margins: A structural estimation for anti-ulcer drugs in France 0 0 0 74 0 3 11 348
The use of scanner data for economics research 0 0 0 0 0 0 0 0
Two-Part Tariffs versus Linear Pricing Between Manufacturers and Retailers: Empirical Tests on Differentiated Products Markets 0 0 0 72 3 4 9 363
Two-Part Tariffs versus Linear Pricing Between Manufacturers and Retailers: Empirical Tests on Differentiated Products Markets 0 0 0 54 1 8 16 309
Two-Part Tariffs versus Linear Pricing between Manufacturers and Retailers: Empirical Tests on Differentiated Products Markets 0 0 0 85 4 5 9 320
Two-part tariffs versus linear pricing between manufacturers and retailers: empirical tests on differentiated products markets 0 0 0 169 1 5 18 892
What Does It Take to Become a Good Mathematician? 0 0 0 85 0 2 4 332
Total Working Papers 10 21 93 7,040 136 983 1,809 31,106
2 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Aléa moral, fertilité de la terre et choix de contrats aux Philippines 0 0 0 5 1 3 4 83
Assurance complète, hétérogénéité des préférences et métayage au Pakistan 0 0 0 0 0 3 5 11
Child Care Provision: Semiparametric Evidence from a Randomized Experiment in Mexico 0 0 0 12 0 12 15 74
Consommation, partage de risque et assurance informelle: développements théoriques et tests empiriques récents 0 0 0 8 23 74 79 226
Do Prices and Attributes Explain International Differences in Food Purchases? 1 1 1 106 2 10 16 490
Effects of front-of-pack labels on the nutritional quality of supermarket food purchases: evidence from a large-scale randomized controlled trial 0 1 2 11 1 8 21 137
Effects on School Enrollment and Performance of a Conditional Cash Transfer Program in Mexico 0 2 4 165 6 15 26 800
Efficacité des contrats agricoles: le cas de la production de blé en Midi-Pyrénées 0 0 0 6 1 4 6 28
Efficiency of agricultural contracts: the case of wheat production in South-Pyrenees 0 0 0 0 0 0 1 9
Empirical Evidence on Satisfaction with Privatization in Latin America 0 0 0 7 0 5 9 84
Empirical Evidence on the Role of Nonlinear Wholesale Pricing and Vertical Restraints on Cost Pass-Through 0 1 5 104 3 7 28 364
Formal and Informal Risk Sharing in LDCs: Theory and Empirical Evidence 0 0 0 148 0 5 7 503
Grower Risk Aversion and the Cost of Moral Hazard in Livestock Production Contracts 0 0 0 43 0 2 10 146
Household food consumption, individual caloric intake and obesity in France 0 0 0 12 0 5 10 102
How Well Targeted Are Soda Taxes? 0 0 2 52 1 4 14 270
Identifying Industry Margins with Price Constraints: Structural Estimation on Pharmaceuticals 1 2 6 46 1 19 30 247
Identifying the effect of unobserved quality and expert reviews in the pricing of experience goods: Empirical application on Bordeaux wine 1 1 2 91 1 2 8 303
Identifying the effects of scientific information and recommendations on physicians’ prescribing behavior 0 1 1 3 0 2 4 20
Impacts of Patent Expiry on Daily Cost of Pharmaceutical Treatments in Eight OECD Countries, 2004--2010 0 0 0 20 1 3 5 61
Incentives to Invest in Short-Term vs Long-Term Contracts: Theory and Evidence 0 0 0 11 0 3 4 101
Inference on vertical contracts between manufacturers and retailers allowing for nonlinear pricing and resale price maintenance 0 2 5 111 1 7 24 380
Introduction 0 0 0 32 0 1 1 97
Introduction to the special issue on the Econometrics of Auctions 0 0 0 44 0 6 11 145
Les relations entre producteurs et distributeurs, une analyse économique et économétrique de mécanismes inflationnistes sur les prix de détail 0 0 0 0 0 2 2 20
Market size and pharmaceutical innovation 0 1 4 45 1 13 38 223
Moral hazard, land fertility and sharecropping in a rural area of the Philippines 0 0 1 144 1 6 11 419
On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector 0 0 1 13 4 6 14 104
Optimal Regulation of Private Production Contracts with Environmental Externalities 0 0 0 41 0 1 2 143
Optimal incentives under moral hazard and heterogeneous agents: Evidence from production contracts data 0 0 1 42 1 5 14 180
Optimal intertemporal curative drug expenses: The case of hepatitis C in France 0 0 0 0 1 5 13 13
Pooled procurement of drugs in low and middle income countries 1 2 9 48 3 9 28 165
Producer-retailer relationships, an economic and econometric analysis of inflationist mechanisms on retail prices 0 0 0 1 0 7 8 28
Product design and decision rights in vertical structures 0 0 0 4 0 4 8 58
Productivity and mobility in academic research: evidence from mathematicians 0 0 1 6 1 9 14 61
Reflecting on the First 20 Years of the Journal of the European Economic Association 0 0 0 3 0 3 5 12
Rotten Parents and Child Labor 0 0 0 157 0 0 7 683
Smoking within the Household: Spousal Peer Effects and Children’s Health Implications 0 0 0 8 1 2 2 66
The Effects of Banning Advertising in Junk Food Markets 0 1 2 38 2 12 47 445
The Market of Academic Journals: Evidence from Data on French Libraries 0 0 0 32 0 7 14 179
The Use of Scanner Data for Economics Research 1 1 3 14 2 6 27 65
Total Journal Articles 5 16 50 1,633 59 297 592 7,545


Statistics updated 2026-04-09